Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Petros Isaakidis a Clinical Trials and Evidence
Based Medicine Unit, Department of Hygiene and Epidemiology, University
of Ioannina School of Medicine, Ioannina, Greece, b South African Cochrane Center, South
African Medical Research Council, Cape Town, South Africa
Correspondence to: J P A
Ioannidis jioannid{at}cc.uoi.gr
Objective:
To evaluate whether the amount of
randomised clinical research on various medical conditions is related
to the burden of disease and health needs of the local populations in
sub-Saharan Africa.
What is already known on this topic
Little clinical research is conducted for problems affecting
sub-Saharan Africa What this study adds
Correlation between the amount of randomised evidence and the estimated
burden of disease was fairly good However, some disease categories were more neglected than others, with
the worst being injuries
Design:
Construction and analysis of comprehensive database of randomised controlled trials in sub-Saharan Africa based on
Medline, the Cochrane Controlled Trials Register, and several African databases.
Setting:
Sub-Saharan Africa.
Main outcome measures:
Number of trials and randomised
subjects for each category of disease in the global burden of disease
taxonomy; ratios of disability adjusted life years (DALYs) per amount
of randomised evidence.
Results:
1179 eligible randomised controlled trials were identified. The number of trials published each year increased over time. Almost half of the trials (n=565) had been done in South
Africa. There was relatively good correlation between the estimated
burden of disease at year 2000 and the number of trials performed
(r=0.53, P=0.024) and the number of participants randomised (r=0.68, P=0.002). However,some conditions
for
example, injuries (over 20 000 DALYs per patient ever
randomised)
were more neglected than others.
Conclusion:
Despite recent improvements, few clinical trials are done in sub-Saharan Africa. Clinical research in this part
of the world should focus more evenly on the major contributors to
burden of disease.
Sub-Saharan Africa has a large burden of disease
Only 1179 randomised controlled trials conducted in sub-Saharan Africa
in the past 50 years were identified
Read all Rapid Responses